ASSENT-3 PLUS published: Enoxaparin dose adjustment needed in older patients when given with thrombo
Uppsala, Sweden - The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS study, comparing enoxaparin with unfractionated heparin given with tenecteplase in a ...
The objective of our study was to determine the feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates, and to assess response to treatment. Nineteen premature and ...
Aug. 18, 2004 — The U.S. Food and Drug Administration (FDA) and Aventis Pharmaceuticals notified healthcare professionals in March of revisions to the precautions section of drug labeling for ...
Effects of admission (adm) source, time, and provider on inpatient (inpt) oncology (onc) outcomes at the Cleveland Clinic Foundation (CCF).
(HealthDay)—Once-daily enoxaparin is associated with fewer major bleeds than enoxaparin twice daily in patients with acute venous thromboembolism (VTE), according to a study published online Jan. 25 ...
Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...
Sanofi's unit in Spain has unleashed a mobile app called CLX Dosis for calculating doses of its anticoagulant Clexane (enoxaparin). As PMLive reports, the French drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results